The House resumed from April 3 consideration of the motion that Bill C-307, An Act to amend the Controlled Drugs and Substances Act (tamper resistance and abuse deterrence), be read the second time and referred to a committee.
In the House of Commons on April 5th, 2017. See this statement in context.